---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-085057"
form_type: "8-K"
ticker: "ITRMF"
cik: "0001659323"
company_name: "Iterum Therapeutics plc"
filed_at: "2024-07-22T23:59:59+00:00"
generated_at: "2026-05-31T18:33:40.335667+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Iterum Therapeutics launches rights offering of up to $10.3M in Units at $1.21/unit

## Summary
- Maximum 8,503,800 Units offered at $1.21/unit; each Unit includes one ordinary share, a 0.5-share 1-year warrant, and a 1-share 5-year warrant.
- Subscription period July 22 to August 6, 2024; rights are non-transferable; proceeds if fully subscribed ~$10.3M.
- Record date July 16, 2024; each shareholder/warrant holder receives one right per share/warrant to purchase 0.5 Units.
- One eligible warrant holder waived participation; Maxim Group LLC is dealer-manager.
- Rights offering previously disclosed; registration statement declared effective by SEC.

## SEC filing metadata
- accession: 0000950170-24-085057
- form_type: 8-K
- ticker: ITRMF
- cik: 0001659323
- company_name: Iterum Therapeutics plc
- filed_at: 2024-07-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1659323/000095017024085057/0000950170-24-085057-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1659323/000095017024085057/itrm-20240722.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-085057
- JSON: https://secwatch.observer/filing/0000950170-24-085057.json
- Plain text: https://secwatch.observer/filing/0000950170-24-085057.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.